Search

Search Results

• Retrospective multicenter study on severely dysplastic melanocytic nevi: evaluating the need for re-excision and the risk of recurrence or progression

  Cesare Ariasi, Carlo Cota, Cesare Massone, Carmine D'Acunto, Pietro Danese, Maurizio Lombardo, Davide Melandri, Francesca Scarpellini, Rosa Rinaldi, Paola Pasquini, Paolo Incardona, Piergiacomo Calzavara-Pinton, Paola Monari

  22-05-2025

  https://doi.org/10.4081/dr.2025.10349

  114

  PDF: 66

• When mycosis fungoides seems not to be within the spectrum of clinical and histopathological differential diagnoses

  Monia Di Prete, Andrea Michelerio, Viviana Lora, Carlo Francesco Tomasini, Carlo Cota

  07-05-2024

  https://doi.org/10.4081/dr.2024.10008

  468

  PDF: 429

• Annular elastolytic giant cell granuloma after COVID-19 vaccination

  Viviana Lora, Arianna Lamberti, Monia Di Prete, Dario Graceffa, Carlo Cota

  12-09-2023

  https://doi.org/10.4081/dr.2023.9811

  817

  PDF: 244

  HTML: 32

• Regenerative therapies in lichen sclerosus genitalis patients and possible efficacy in preventing squamous cell carcinoma development: a long-term follow-up pilot study

  Marinella Tedesco, Barbara Bellei, Lavinia Alei, Monia Di Prete, Carlo Cota, Tiziano Pallara, Antonio Bonadies, Alessandra Latini, Stefania De Fazio, Emilia Migliano

  27-11-2024

  https://doi.org/10.4081/dr.2024.10079

  393

  PDF: 225

• Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

  Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

  11-11-2024

  https://doi.org/10.4081/dr.2024.10140

  636

  PDF: 290

  SUPPLEMENTARY: 49

• Can hydradenitis suppurativa be associated with inflammatory joint involvement? Report of a case series and review of the literature

  Dario Graceffa, Martina Silvestri, Norma Cameli, Viviana Lora, Antonio Cristaudo, Claudio Bonifati, Carlo Cota, Pier Luigi Saraceni

  11-09-2023

  https://doi.org/10.4081/dr.2023.9815

  656

  PDF: 314

  HTML: 9